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Abstract
Background: International guidelines on type 1 diabetes advocate routine screening of health-related quality of
life (HRQOL). DISABKIDS questionnaires are the first instruments developed across cultures and nations to provide
age-appropriate measures of HRQOL in children with chronic diseases. DISABKIDS includes a Chronic Generic
Module 37 (DCGM-37) and disease-specific modules. The purpose of this study was to examine reliability and
validity of the Norwegian versions of the DISABKIDS questionnaires in children and adolescents with type 1
diabetes.
Methods: The DCGM-37 and the Diabetes Specific Module-10 (DDM-10) were translated into Norwegian using
standard forward-backward translation. Eight to 19 year old children and adolescents with type 1 diabetes
scheduled for routine follow-up at three diabetic clinics in Norway and one of their parents were invited to
complete the DCGM-37 and the DDM-10. Internal consistency was determined using Cronbach’s alpha. Results
were compared with those of the Child Health Questionnaire Children Form-87 (CHQ-CF87) and Child Health
Questionnaire Parent Form-50 which are established generic questionnaires. DISABKIDS results were related to age,
gender, duration of diabetes, mode of insulin delivery and metabolic control. Clinical data were obtained from the
Norwegian Childhood Diabetes Registry.
Results: Of 198 eligible child-parent dyads, 103 (52%) completed the questionnaires. Mean age was 13.6 (2.6),
range 8-19 yrs, 52% were boys. Cronbach’s alpha was > 0.70 for all the DISABKIDS sub-scales except two (physical
ability and social inclusion). There were moderate to high correlations (0.65-0.81) between the DISABKIDS scales
and mental/emotional sub-scales of CHQ-CF87. Increasing age and higher HbA1c were significantly associated with
reduced HRQOL scores. Parents tended to score their child’s HRQOL lower than the children/adolescents
themselves.
Conclusions: The study shows that the DISABKIDS instruments are applicable to a Norwegian childhood diabetes
population. They seem to be a relevant supplement to other clinical indicators in medical practice and research.
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Introduction
Type 1 diabetes is one of the most common chronic dis-
eases of childhood, and the incidence in Norway of 30 new
cases per 100 000 person years is one of the highest in the
world [1]. Diabetes poses significant every-day challenges
since optimal blood glucose control is important in order
to avoid severe acute complications (i.e. hypoglycaemia and
diabetes ketoacidosis) and long term consequences, such as
early onset of cardiovascular disease, visual impairments,
renal failure, neuropathy and premature death [2,3]. The
burden of diabetes on the children and their families is
well known to affect both psychological and total wellbeing
[4-6], and young persons with diabetes report impaired
self-perceived health-related quality of life (HRQOL) [7,8].
A good quality of life is an important treatment goal in
itself [9], but is also important in order to achieve other
treatment goals [10-13]. The International Society for
Pediatric and Adolescent Diabetes-(ISPAD) guidelines
therefore advocate assessment of quality of life as impor-
tant as screening for other complications related to dia-
betes [9,14]. HRQOL is a multidimensional construct
including at least physical, psychological and social
domains. To make international comparisons possible it is
advocated that test instruments are developed in cross-cul-
tural and cross-national study groups [15,16]. In line with
this goal “The DISABKIDS project”, which was funded by
the European Commission, was developed in seven
European countries with the purpose of developing instru-
ments for assessing HRQOL of children with different
chronic health conditions [16,17]. The DISABKIDS instru-
ments consist of questionnaires which include a generic
module (DISABKIDS Chronic Generic Module (DCGM-
37)) and disease-specific modules (e.g. DISABKIDS
Diabetes- Specific Module (DDM-10)) [18]. The DCGM-
37 is the only HRQOL instrument developed across cul-
tures for children with chronic diseases [19]. Due to its
novelty, relatively few studies using DISABKIDS have been
published so far, apart from the psychometric properties
reported from the European field study [17]. A literature
search disclosed no recent validation studies, but Swedish
and Greek groups have published results on DISABKIDS
data [19-21].
The aims of the present study were to examine reliabil-
ity and validity of the Norwegian versions of the DCGM-
37 and DDM-10 questionnaires when assessing HRQOL
among children and adolescents with type 1 diabetes
based on their own report and that of their parents.
Internal consistency was assessed by Cronbach’s alpha
coefficient. Convergent validity was assessed by compari-
son with established generic instruments, in this case the
Child Health Questionnaire Children Form-87 (CHQ-
CF87) and Child Health Questionnaire Parent Form-50
(CHQ-PF50). We also evaluated the instruments’ ability
to discriminate between patients with different character-
istics, i.e. age, gender, duration of disease, treatment
modalities and metabolic control reflected in HbA1c.
Finally, we studied whether the children and their parents
assessed the child’s HRQOL differently.
Methods
Participants
Except for families who were not able to speak or read
Norwegian, all 8-19 year old children or adolescents
with type 1 diabetes scheduled for follow-up at three
pediatric departments in eastern Norway between Octo-
ber 1st, 2009 through February 28th 2010 and one of
their parents were invited by mail to participate in the
study before a scheduled consultation.
Whether the cohort in the present study was repre-
sentative for Norwegian children and adolescents with
diabetes was assessed by comparing demographic and
clinical characteristics with that of the Norwegian Child-
hood Diabetes Registry, which is a population based,
nationwide registry covering all pediatric departments in
Norway. In 2010, 95% of all children and adolescents
with diabetes treated by pediatricians were included in
the registry [22].
Instruments
DISABKIDS
The DISABKIDS Chronic Generic Module (DCGM-37)
is a questionnaire which measures general HRQOL and
the level of distress caused by a chronic disease, and can
be supplemented with condition-specific modules for
asthma, arthritis, cerebral palsy, cystic fibrosis, dermati-
tis, epilepsy and diabetes [18]. The instruments include
one form to be filled in by children between 8 and 18
years of age, and one form for their parents. A four-
week recall period is used for all items except item 11
“About symptoms” which has a one year recall in the
diabetes specific module.
The DCGM-37 questionnaire contains 37 items which
explore six dimensions of HRQOL [16,17] (Figure 1):
“Mental independence” assesses whether the child feels
confident about the future and is able to live an autono-
mous life without impairments caused by the condition,
“Mental emotion” addresses emotional reactions, such as
worries, concerns, anger and problems caused by the
child’s condition, “Social exclusion” deals with the feeling
of being left out and stigmatized, “Social inclusion” focuses
on positive social relationships and the understanding of
others, “Physical limitation” refers to somatic limitations,
due to the condition and “Physical treatment” assesses the
impact of taking medication, receiving injections, etc.
Each item is scored on a five-point Likert scale indi-
cating frequency of behaviours or feelings as 1 = never,
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2 = seldom, 3 = quite often, 4 = very often, 5 = always.
The scale for negatively worded items was reversed
according to the manual. In computation of sum scores,
missing values were substituted with the mean of non-
missing items if only one item of the domain was miss-
ing. If more than one item was missing the domain was
not scored. The sum score of each domain is the sum
of the single item scores. From the raw score a total
score may be computed with a range from 0 to 100
with higher scores indicating higher self-perceived
HRQOL.
The diabetes specific instrument (DDM-10) consists of
an “Impact” and a “Treatment” scale (Figure 2). The
“Impact scale” deals with emotional reactions of blood
glucose control and adhering to diets in everyday life,
and the “Treatment scale” deals with emotional reactions
to the planning of treatment and the burden of carrying
equipment. DDM -10 items are scored on a five-point
Likert scale, and a 0-100 score is calculated for each sub-
scale [23].
The DCGM-37 and DDM-10 forms were forward and
backward translated from English to Norwegian according
to an international scientific translations procedure [24].
The goal of this process was to keep the original
meaning of the questions and simultaneously to find the
most appropriate terms in the new language. The final
versions were approved by the DISABKIDS research
group.
A standard manual detailing the data collection was
distributed to each of the three participating centres.
In the past, presentations of HRQOL results have
been criticised for being incomprehensible in relation to
Figure 1 The structure of the DISABKIDS Chronic Generic Module-37, (DCGM-37), included rephrased, positive subscales, (in
parenthesis).
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clinical relevance [25]. To address this critique, Osobo
et al have suggested that HRQOL results will be more
meaningful if negative domains were reconceptualised to
positive statements [20,26]. Therefore, in the following,
similar to the presentation of results from Chaplin and
colleges [20]“Mental emotion” is rephrased as “Inner
strength”, “Social exclusion” as “Social equality”, and
“Physical limitations” as “Physical ability”.
Child Health Questionnaire
In additions to the DISABKIDS questionnaires, the chil-
dren and adolescents were asked to complete the Child
Health Questionnaire Form-87 (CHQ-CF87), and their
parent the Child Health Questionnaire Parent form-50
(CHQ-PF50). The CHQ-CF87 is a generic HRQOL ques-
tionnaire designed to measure physical, emotional, beha-
vioural and social well being [27]. From 10 years of age
children were asked to complete the CHQ-CF87 indepen-
dently, while the questions could be read to younger
children [28,29].
Health is assessed over several domains i.e. general
health perceptions, physical functioning, role/social- phy-
sical functioning, bodily pain, role/social- emotional and
behavioural functioning, parent impact-time and parent
impact-emotional, self-esteem, mental health, behaviour,
family activities and family cohesion. The responses are
indicated on 4 to 6 point Likert scales specifying level of
agreement to a certain categorical statement such as
“very often” to “not at all”. The responses within each
subscale are summed, and the raw scores are transformed
to a score between 0 and 100, with higher scores indicat-
ing better functional health and well-being. Extensive
studies on the psychometric properties of the CHQ-CF87
and CHQ-PF50 suggest strong internal consistency,
content validity and construct validity. Translation to
Norwegian has been carried out previously, and the
instruments have been used in several Norwegian patient
cohorts [30-32]. A four- week recall period is used for all
scales except for the “Change in Health” and “Family
Cohesion” items which refer to last year, and the
“General health” scale which has no recall period.
The questionnaires were completed at the clinic when
the participants met for their follow up. As recom-
mended for CHQ-87, health care personnel were avail-
able to clarify questions for the age group 8-9 years, if
necessary. The child/adolescent and their parent com-
pleted the questionnaire independently of each other.
The completed questionnaires were scanned using
Tele Form (Cardiff software, Vista, CA) and checked for
scanning errors.
Clinical characteristics
HbA1c was analyzed at the same visit as the question-
naires were filled in using Bayer DCA 2000 (Tarrytown,
NY - normal reference range 3.4-6.1%). The incidence
of reported ketoacidosis and hypoglycaemia was too low
to allow analyses of HRQOL scores in relation to these
clinical markers.
Ethical considerations
The children and adolescents and their parents gave
written consent according to Norwegian requirements.
The study was approved by the Regional committee on
medical research ethics.
Statistical analyses
Results are presented as means with one standard devia-
tion (SD) or as rates (percentages). Floor and ceiling
effects are reported in numbers of patients with HRQL
scores of 0 (floor) and 100 (ceiling). A percentage above
25 was characterized as high.
Internal consistency refers to the degree to which the
different items in a scale measure the same construct.
For the DISABKIDS questionnaires reliability was
assessed by tests of internal consistency of each of the
subscales and the overall sum score. Cronbach’s alpha
coefficients above 0.70 are generally viewed as accepta-
ble when instruments are used for group level analyses
[33,34]. With short scales as in DCGM-37 and DDM-10
it is often more appropriate to report mean inter item
correlations. Upper and lower limits of mean inter item
correlations are a matter of discussion. Some authors
claim that values between 0.2 and 0.4 are optimal [35],
while others argue that a mean inter item correlation
consistently above 0.70, may indicate redundancy [36].
In the present article, we consider mean inter item cor-
relations between 0.2 and 0.7 as satisfactory.
Convergent and divergent validity of the DISABKIDS
questionnaires DCGM-37 and DDM-10 were assessed
with reference to the generic questionnaires CHQ- CF87
and CHQ-PF50, respectively, using Pearson correlation
adjusted for age and gender. A correlation coefficient (r)
Figure 2 The structure of the DISABKIDS Diabetes Module-10
(DDM-10).
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above 0.5 between measures of construct related to each
other was considered as high and a coefficient between
0.3 and 0.5 as moderate convergence, while measures
were not considered to be related if correlation coeffi-
cients were below 0.3 [34].
DISABKIDS’ discriminant validity in relation to age,
gender, duration of diabetes, mode of insulin delivery
and metabolic control (i.e. levels of HbA1c) was assessed
using multiple regression analysis.
Paired sample t-tests were used to assess associations
between scores obtained by the children and their
parents.
Significance was defined as p < 0.05. SPSS version 18.0
(SPSS IBM, NY, USA) was used for analyses.
Results
Of 198 eligible child-parent dyads 103 (52%) completed
the questionnaires. Mean age was 13.6 (2.6), range 8-19
years, and 53 (52%) were boys. Compared with the
national diabetes cohort, the participants had similar gen-
der distribution, mean age, mean duration of diabetes and
mean body mass index (BMI), but somewhat lower mean
HbA1c, lower average numbers of consultations and
higher rate of insulin pump use (Table 1).
Mean scores on the children’s and adolescents’ self
report forms varied between 62 and 83. Very few had
floor or ceiling values (Table 2).
Reliability
For the children’s questionnaires the internal consistency
of the DCGM-37, calculated as Cronbach’s alpha, varied
between 0.55 and 0.92 (Table 2.). Cronbach’s alpha was
above 0.70 for all subscales except for “Physical ability”
and “Social inclusion”. Mean inter item correlations were
above 0.20 and below 0.50 for all subscales except for the
“Physical ability” subscale which was 0.19. For the DDM-
10 Cronbach’s alpha was 0.79 for both scales, and mean
inter-item correlations were 0.41-0.49.
For the parent’s questionnaires, Cronbach’s alpha var-
ied between 0.74 and 0.89 for the DCGM-37 and was
0.83 for both scales on the DDM-10. Mean inter item
correlations varied from 0.32 (“Physical ability”) to 0.55
(“Inner strengths”).
Convergent validity
Correlation coefficients between the DCGM-37 and
DDM-10 scales and the “Mental health” subscale in
CHQ-CF87 were in the range 0.54-0.81 (Table 3). Cor-
relation coefficients were in the range 0.65-0.81 between
the DCGM-37 total score and six of the twelve sub-
scales in the CHQ-CF87, and in the range 0.49-0.67
between “Role emotional” in CHQ-87 and the DCGM-
37 “Treatment” scale and the DDM-10 ("Impact” and
“Treatment” scales).
Correlation coefficients between the DCGM-37 scales
and the CHQ-CF87 scales “Physical function” “Role
behavioral”, “Global behavior” and family related dimen-
sions were low.
Discriminant validity
The generic as well as the diabetes-specific module of
DISABKIDS discriminated between age groups and
levels of HbA1c (Table 4). Higher age and increasing
HbA1c were associated with lower HRQOL scale scores.
Boys tended to score higher than girls, and children
using insulin pump higher than those on multi-injections
on total sum-scores and scores on most subscales. With
respect to treatment modality, the differences in mean
score between insulin pump and multi-injection users
were between 3.5-4.0 on “Social equality “and “Physical
treatment” subscales on DCGM-37 as well as for both
subscales in the DDM-10 (results not shown).
Table 1 Demographic and clinical characteristics of the children and adolescents included in the Norwegian Childhood
Diabetes Registry and the study population.
Norwegian Childhood Diabetes Registry
(n = 2109)
Study cohort
(n = 103)
p
Number
examined
Number examined
HbA1c (%) - mean (SD) 2048 8.65 (1.4) 101 8.04 (1.1) < 0.001
Boys - n (%) 2109 1114 (53) 102 53 (52.0) 0.92
Age(yrs)-mean (SD) 2109 12. 9 (3.8) 102 13.6 (2.6) 0.07
BMI kg/m2- mean (SD) 2081 20.4 (3.9) 100 20.8 (3.6) 0.29
Consultations last year
- mean (SD)
2068 3.7 (1.7) 102 3.3 (1.3) 0.02
Diabetes duration (yrs)
-mean (SD)
2109 5.2 (3.6) 102 4.6 (3.5) 0.06
Insulin pump - n (%) 2109 1073 (51) 102 74 (73) < 0.001
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There were no differences in scores with regard to dura-
tion of diabetes. Twelve (12%) of the participants had dia-
betes duration of less than one year. This group scored
slightly higher on all subscales as well as on the HRQOL
total score, but these differences were not statistically
significant.
Comparison of children’s and parents’ scores
Generally, children and adolescents tended to give higher
scores than their parents. This was true for all subscales in
DCGM-37 and for the “Impact” scale in DDM-10. Signifi-
cant mean (SD) differences were found for the DCGM-37
total score (78 ± 11.0 vs. 76 ± 11.1, p = 0.03), the subscales
Table 2 Subscale and total sum scores on the Norwegian self report version of DISABKIDS.
Scale n Mean score
(1-100)
Standard
Deviation
Floor/ceiling
n/n
“Chronbach alpha” Mean inter-item
correlation
Mental Mental independence 103 78 13.7 0/7 0.75 0.33
Mental Emotion
(Inner strength)
103 77 15.6 0/8 0.85 0.47
Social Social Inclusion 102 80 11.5 0/3 0.60 0.22
Social exclusion
(Social equality)
103 83 13 0/8 0.70 0.30
Physical Physical limitations
(Physical ability)
103 77 11.4 0/5 0.55 0.19
Medication/Treatment 101 75 17.2 0/9 0.80 0.40
Total score HRQOL 100 78 16.9 0/0 0.92 0.25
Diabetes module Impact 102 70 16.9 0/6 0.79 0.41
Treatment 100 62 20.7 1/5 0.79 0.49
All subscales are scored from 0 to 100 with higher scores indicating higher self-perceived HRQOL.
Table 3 Correlationsa between the DISABKIDS and the CFQ-CF87 scales in a cohort of 103 children and adolescents
with type 1 diabetes
CHQ-CF87 DISABKIDS
DCGM-37 DDM-10
Mental Independence
(Inner strength)
Mental
Emotion
Social
Excl
Social
Incl
(Equality)
Physical limitations
(abilities)
Treatment DCGM-37
sumscore
DDM
impact
DDM
treatment
Physical
function
0.21 0.15 0.21 0.21* 0.06 0.20 0.22 * 0.19 0.19
Role
emotional
0.30** 0.39*** 0.28** 0.27* 0.36** 0.59*** 0.81*** 0.67*** 0.49***
Role
behavioral
0.20 0.23* 0.15* 0.11 0.32** 0.23* 0.27* 0.22* 0.19
Role
physical
0.26* 0.18 0.21* 0.17 0.34*** 0.22* 0.29** 0.30** 0.15
Bodily pain 0.47*** 0.51*** 0.56*** 0.49*** 0.54*** 0.49*** 0.65*** 0.38*** 0.22*
Behavior 0.56*** 0.59*** 0.45*** 0.45*** 0.64*** 0.60*** 0.70*** 0.54*** 0.58***
Global
behavior
0.26* 0.32** 0.23* 0.315** 0.32** 0.19 0.34*** 0.26* 0.05
Mental
health
0.69*** 0.71*** 0.58*** 0.59*** 0.71*** 0.57*** 0.81*** 0.54*** 0.55***
Self-esteem 0.60*** 0.58*** 0.52*** 0.58*** 0.64*** 0.50*** 0.72*** 0.51*** 0.44***
General
health
0.54*** 0.59*** 0.54*** 0.55*** 0.60*** 0.50*** 0.70*** 0.51*** 0.44***
Change in
Health
0.21* 0.25* 0.13 0.16 0.23* 0.07* 0.22* 0.11 0.11
Family
activity
0.32* 0.33*** 0.24* 0.14 0.22* 0.34*** 0.35*** 0.34*** 0.38***
Family
cohesion
0.33*** 0.26* 0.35*** 0.36*** 0.45*** 0.31** 0.43*** 0.26* 0.28**
a Pearsons’s correlation coefficient adjusted for age and gender
*p < 0.005. **p < 0.01. ***p < 0.001
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“Inner strength” (77 ± 15.8 vs. 72 ± 13.1, p < 0.01) and
“Social inclusion” (80 ± 11.7 vs. 74 ± 15,0 p < 0.001). In
the DDM-10 “Treatment” scale parents tended to score
higher than their children (66 ± 17.1 vs. 63 ± 20.4 p =
0.14).
Discussion
Applied to this Norwegian child and adolescent popula-
tion with diabetes and their parents the internal consis-
tency reliability of the DISABKIDS instruments was
satisfactory for all except two scales judged by Cron-
bach’s alpha. Furthermore, the scores on the DCGM-37
subscales showed moderate to high correlations with the
“Mental health” subscale, but low correlations with the
“Physical function” and family related subscales on the
previously validated CHQ-CF87 and CHQ-PF50 ques-
tionnaires. The DISABKIDS instruments discriminated
between groups based on metabolic control (HbA1c) and
age in that increasing HbA1c and age were associated
with lower HRQOL, while no significant differences were
found with respect to gender, duration of diabetes or
insulin pump vs. multi-injections treatment, although
there was a tendency that pump-users rated the impact
of disease less and social equality higher than those on
multi-injections. Parents generally scored their children’s
HRQOL lower than the children and adolescents
themselves.
Strengths and limitations
The major strength of the study was that the DISAB-
KIDS questionnaires were applied to a wide age-range
of children and adolescents (8-19 years old). Also, a
broad perspective was taken by the collection of both
self-reported and parent data. Furthermore, the results
of the DISABKIDS were compared with those obtained
with a HRQOL instrument (CHQ) which is well vali-
dated in Norwegian populations. Major weaknesses were
the limited sample size and low participation rate. The
reasons why 48% of the total population did not partici-
pate were multifactorial. The main reason reported by
the nurses at the participative centers was that not all
families were approached during periods with large
work load in the clinic. However, this happened at ran-
dom and we are confident that it did not introduce a
bias.
Compared to the children registered in the national dia-
betes registry the study cohort had a somewhat lower
mean HbA1c and higher proportion of insulin pumps
users, but we still suggest that the results are representa-
tive of the national cohort for the following reasons: The
difference in mean HbA1c was probably too small to be of
major significance, and the difference in proportion of
pump users was likely due to differences in treatment tra-
ditions. In Norway, pumps are, in practice, available with-
out extra charge for all children, and the proportion
choosing pumps is mainly a result of how familiar and
confident the medical staff is with this modality. The
clinics participating in the study have an active approach
to encourage the use of pump, and the proportion of
pump users in the study group was similar to the propor-
tion among all the patients followed in the clinics.
Due to the relatively small sample size we did not per-
form factor analyses to assess the factor structure of the
DCGM-37 or DDM-10 instruments, which is advocated
when the instrument is applied to a larger population.
With regard to reliability the study may be criticised for
not applying test- retest reliability scores. However, this
Table 4 Effects of age and HbA1c on total and self reported scores in DISABKIDS.
Age HbA1c
Subscale Unadjusted effect p Adjusted
effecta*
P Unadjusted effect p Adjusted
effecta**
p
Total sum- score HRQOL -0.94 0.08 -0.94 0.04 -2.49 0.01 -2.40 0.01
Mental Mental independence -0.78 0.15 -0.87 0.13 -0.58 0.64 0.62 0.62
Mental Emotion
(Inner strength)
-1.58 0.01 -1.684 0.01 -2.77 0.05 -2.73 0.05
Social Social inclusion -0.75 0.11 -0.61 0.21 -2.49 0.02 -2.26 0.03
Social exclusion
(Social equality)
-0.57 0.29 -0.48 0.37 -2.16 0.06 -2.02 0.09
Physical Physical limitations
(Physical Ability)
-0.78 0.09 -0.91 0.05 -3.19 0.001 -3.39 0.001
Medication/Treatment -1.27 0.07 -0.97 0.19 -3.77 0.01 -3.37 0.03
Diabetes module Impact -1.47 0.03 -1.38 0.04 -4.43 0.002 -4.38 0.002
Treatment -3.01 0.001* -2.84 0.001 -3.44 0.06 -2.54 0.16
aAdjusted for gender, duration of diabetes and use of insulin pump vs. multi-injections using multiple linear regression analyses
*Effect per year of age, **Effect per % increment of HbA1c.
All subscales are scored from 0 to 100 with higher scores indicating higher self-perceived HRQOL.
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was not included because of concern for the patients and
logistic challenges.
It is suggested that the CHQ-CF87 can be read to
children less than ten years of age. The medical staff,
after piloting, reported that some children between 8-9
years had insufficient reading skills to respond reliably
on the DISABKIDS. Use of the instruments might there-
fore have a limitation in the youngest population if the
questions are not read to them.
Internal consistency
Most of the sub-scales showed Cronbach’s alpha coeffi-
cients above 0.7, which are in agreement with the Eur-
opean field study [17]. The “Physical ability” scale had a
low Cronbach’s alpha compared to what was reported in
the European field study where the patient populations
consisted of seven different chronic conditions [17]. The
“Physical ability” items in the DCGM-37 range from ques-
tions about difficulties with moving and running to ques-
tions on how life is ruled by the condition. Young persons
with diabetes rarely experience physical complications due
to the disease and, therefore, usually have no physical lim-
itations. However, they experience significant practical and
often emotional challenges due to repeated blood glucose
measurements and administration of insulin, fear of hypo-
glycaemia, ketoacidosis and long term complications on a
daily basis. Therefore, a low Cronbach’s alpha was not
unexpected. The Cronbach’s alpha was also low for the
“Social inclusion” subscale. In line with earlier reports, we
suggest that the demands of adhering to treatment may
create a feeling of separation from peers [20]. Also, differ-
ences in the experiences between users of pump and
multi-injection treatments may create an incoherent scor-
ing, explaining the lower alpha on this scale.
In general, few items in a scale, such as six items in the
DISABKIDS subscales, may make Cronbach’s alpha calcu-
lations vulnerable to variations between items, and mean
inter-item (MII) correlation has been suggested as an
alternative analysis of consistency [35]. This method modi-
fies the findings in our study, as only the “Physical ability”
subscale had a MII correlation below the lower acceptable
limit of 0.2 underscoring that this subscale may not be
informative for young people with diabetes. Furthermore,
no scales in the two questionnaires had a MII above 0.50,
strongly suggesting that the items in the scales were not
redundant.
On the parents’ reports Cronbach’s alpha was above 0.7
on all subscales, and consistently higher than those of
their children. Still, the pattern was the same as for their
children in that the same subscales “Physical ability” and
“Social inclusion” had the lowest Cronbach’s alpha. These
findings are in accordance with the European study [24].
The heading in both the child’s and parent’s form
“About your typical day” may not be explicit enough for
young people to connect it to “Physical ability”. Parents,
however, may have interpretive abilities that cause them
to answer more consistently.
Convergent validity
Considering the content of the DISABKIDS question-
naires, some scales were expected to correlate better than
others with the CHQ-CF87 scales. The pattern of associa-
tions between the subscales of the two instruments largely
supported the validity of the DISABKIDS instruments.
The European validation procedure used only a few of the
questions from CHQ-CF87 (personal communication,
John Chaplin, 2009). As far as we know a comparison with
complete CHQ questionnaires has not been done earlier
when examining the validity of DISABKIDS.
Six of the subscales from CHQ-CF87 showed high cor-
relation with DCGM -37 total score. This is as expected
since these six subscales, “Role emotional”, “Bodily pain”,
“Behavior”, “Mental health”, “Self esteem” and “General
health” all have items that are similar to those in the
DCGM-37 Questionnaire. On the other hand, the
DCGM-37 does not have any sub-scales mirroring the
“Change in health”, “Family activity” or “Family cohesion”.
It is therefore appropriate that these scales in CHQ-CF87
showed low correlation with the subscale scores in
DCGM-37. This feature may have clinical and scientific
implication for children with diabetes. Other instruments
than DISABKIDS may therefore be more applicable if the
primary goal is to measure family related factors [37,38].
Furthermore, clinicians and researchers need to be aware
that the DISABKIDS instruments seem to have their
strength in measuring the mental and emotional aspects
rather than detecting physical health and family related
aspects of HRQOL.
The different subscales of the two instruments demon-
strated correlations that may seem surprisingly high or
low with reference to how they are named. However,
when considering the content of the respective items in
the DCGM-37 and CHQ-CF87, associations were mainly
as expected. For example, the names of the subscales
“Physical ability” in the DCGM-37 and “Physical function”
in the CHQ-CF87 give the impression that they measure
similar functions. However, the “Physical function” sub-
scale in CHQ-CF87 measures limitation in nine specific
physical activities due to health problems, while DCGM
-37’s “Physical ability” scale is constructed differently, e.g.-
items like “Is your life ruled by you condition” and “Does
it bother you that you have to explain to others what you
can and can’t do?” measure emotional reactions to living
with impairments, while the CHQ-CF87 to a larger extent
addresses physical limitations. The “Physical ability” sub-
scale in DCGM-37 correlated best with “Mental health” in
CHQ-CF87, suggesting that the six questions measure a
wider construct than physical abilities alone.
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“Inner strength” (DCGM-37) correlated well with
“Mental health” (CHQ-CF87) as would be expected due
to the construction of single items in the two scales.
The same was true for “Mental independence” in DIS-
ABKIDS vs. “Mental health” and “Self esteem” subscales
in CHQ-CF87. The three constructs “Mental health”,
“Self esteem” and “General health” in CHQ-CF87 have
40 items covering most of the 37 item DISABKIDS
questionnaire. The DCGM-37 therefore seems to be
well suited for measuring the mental and emotional bur-
den of a disease like diabetes.
The two DDM-10 subscales “Impact” and “Treatment”
and correlated well with the “Role emotional” subscale
on the CHQ-CF87. The two DDM-10 subscales actually
measure the emotional consequences of having a
chronic illness, quite similar to what “Role emotional”
measures. The “Treatment scale” in DCGM-37 and the
“Role emotional” scale were similarly correlated. These
findings suggest that the DISABKIDS instruments are
suitable for an early detection of mental and emotional
worries with possible negative influence on self-manage-
ment. The fact that these instruments are available as
computer programs and can be completed by the
patient and automatically scored prior to consultation,
make them particularly attractive in clinical practice
[39].
Discriminant features
The DISABKIDS generic instrument discriminated
between patients based on age and metabolic control. It is
likely that the scores on both of these variables have clini-
cal significance as well [34]. Older children scored lower
than the younger, a finding that is consistent with other
studies on HRQOL using different instruments [31,40].
The effect of age may indicate a higher level of stress dur-
ing puberty and late adolescence because of greater
responsibility for own disease management and better cog-
nitive ability to understand possible consequences of the
disease, while parents, by taking more responsibility, tend
to relieve the younger children from psychosocial burden
[40].
The finding of higher HRQOL score with better meta-
bolic control is also in accordance with earlier studies [41].
The fact that the DISABKIDS instruments are able to
identify these differences is important, and of interest for
both clinical work and further studies.
The reason why we did not find significant differences in
scores related to gender, type of treatment or duration of
diabetes may be due to lack of statistical power because of
limited sample size. The trends were, however, similar to
what has been found as statistical significant differences in
larger studies [41].
When evaluating differences in HRQOL studies, it is
equally important to evaluate the statistical findings and
numeric differences in scores in relation to clinical
importance. We believe that the statistically significant
findings in our study are clinically significant as well.
Generally, it has been suggested that on a scale of 0-100
a change of 5-10 points is clinically significant for an
individual [34]. The numeric differences between those
using insulin pump and multi-injections on the sub-
scales “Impact” and “Treatment” on DDM-10 and on
“Social equality” on the DCGM-37 may be clinically
important, although they were not statistically significant
in this limited study. The “Social equality” subscale con-
sists of questions regarding external stigma. It has been
reported that pump users have the ability to “hide” their
disease better than those in need of other equipment for
insulin delivery [42]. The feelings of less impact of dis-
ease and smaller problems related to treatment might
therefore contribute to the pump users scoring higher
on this subscale.
In agreement with earlier HRQOL studies we did not
exclude diabetes patients with onset of disease less than
one year prior to the study [40]. Patients with diabetes less
than one year had non-significantly better HRQOL scores
than those with longer duration. The lack of substantial
difference may partly be due to the fact that most of those
with duration less than one year had duration more than 6
months.
The DISABKIDS generic and diabetes specific modules
showed differences between the children’s and parent’s
score. The same findings, with parents tending to perceive
their children’s HRQOL lower than the children them-
selves, have been reported previously, for DISABKIDS as
well as for other HRQOL instruments, and for other
chronic diseases [20,43,44]. These findings may be due to
changes in conceptualization of health related quality of
life over the course of the disease trajectory towards better
acceptance with duration of the disease [31,45]. It is also
notable that the reverse was found on the DDM-10
“Impact scale”, i.e. that disease was felt to have less impact
by the parents than by their children or adolescents. The
reason for this finding is not obvious, but may at least
partly be due to the high proportion of pump users and
parents believing that treatment with pumps implies less
impact of the disease.
Conclusions
The Norwegian version of the child and parent DISAB-
KIDS instruments DCGM-37 and DDM-10 had accepta-
ble reliability and validity in a population of children
and adolescents with type 1 diabetes. DISABKIDS also
discriminated between clinical characteristics that are
important for disease management. We therefore sug-
gest that HRQOL assessment with DISABKIDS may be
of importance as a supplement to other clinical indica-
tors in medical practice and research.
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